Deuruxolitinib
sun pharma
['rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)', 'thrive-aa2', 'deuruxolitinib', 'ruxolitinib', 'concertpharma']
aad 2023 late breaking news. we re excited to share our deuruxolitinib thrive-aa2 phase 3 data in patients with #alopeciaareata during the late -breaking news session at the #aad2023 #aad23latebreaker #knowthescore read more: 
We apply our industry-leading expertise in deuterium chemistry to create and develop innovative drug products that address important patient needs.